Armata Clinical Trials Overview of Bacteriophage Administration for Difficult-to-Treat Infections
Time: 12:00 pm
day: Day One
Details:
- Value of a phage cocktail approach in subjects with chronic pseudomonal respiratory infections
- Similarities of phage distribution and phage kinetics between cystic fibrosis and non-cystic fibrosis bronchiectasis subjects administered nebulized phage (AP-PA02)
- Purity of high dose S. aureus phage (AP-SA02) and ability to safely dose escalate intravenously over multiple days in subjects with S. aureus bacteremia
